Table 1: Clinical characteristics and laboratory findings of the patients.

Group A (GP-placebo tea) Group B (placebo tea-GP)
BaselineWeek 6BaselineWeek 6

8888
Age (years)58.8 ± 5.958.8 ± 5.958.1 ± 6.658.1 ± 6.6
Sex (male : female)5 : 35 : 35 : 35 : 3
Body weight (kg)58.6 ± 5.358.8 ± 5.456.8 ± 4.957.1 ± 5.0
BMI (kg/m2)23.3 ± 1.923.4 ± 2.022.6 ± 1.822.7 ± 1.9
Waist (cm)85.8 ± 6.285.4 ± 5.8 81.0 ± 6.181.9 ± 6.0
Hip (cm)94.4 ± 3.5 94.1 ± 3.391.8 ± 4.291.6 ± 4.0
Systolic blood pressure (mmHg)119.4 ± 10.2119.4 ± 11.5118.2 ± 8.3118.5 ± 7.9
Diastolic blood pressure (mmHg)74.4 ± 5.074.4 ± 4.976.3 ± 4.276.3 ± 5.1
Fasting plasma glucose (mmol/L)8.3 ± 0.87.4 ± 0.68.4 ± 0.78.0 ± 1.0
Fasting plasma insulin (pmol/L)140.98 ± 38.2132.0 ± 109.2113.2 ± 65.3122.9 ± 78.5
HbA1C (%)8.1 ± 0.98.1 ± 0.7
Cholesterol (mmol/L)5.4 ± 0.85.4 ± 1.05.0 ± 0.95.4 ± 1.2a
Triglyceride (mmol/L)2.2 ± 1.52.1 ± 0.92.1 ± 1.12.7 ± 1.3a
HDL-cholesterol (mmol/L)1.5 ± 1.01.2 ± 0.21.1 ± 0.21.1 ± 0.2a
LDL-cholesterol (mmol/L)3.3 ± 1.23.3 ± 1.03.0 ± 0.73.0 ± 0.8a

Results are means ± SD of sixteen patients. a , after removal of one patient with an extreme triglyceride value (12 mmol/L).